ClinicalTrials.Veeva

Menu

Descriptive Analysis of Changes in Hepatitis B Markers in People Living With HIV on Injectable Therapy.

C

Centre Hospitalier Universitaire de Nice

Status

Not yet enrolling

Conditions

Hiv Infection
Hepatitis B

Study type

Observational

Funder types

Other

Identifiers

NCT06421259
24Infectio01

Details and patient eligibility

About

In order to assess the risk of hepatitis B reactivation in people living with HIV and undergoing injection therapy, we propose to carry out a descriptive analysis of the evolution of hepatitis B markers in this population.

Enrollment

15 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

-HIV infected patients under injectable ART

Exclusion criteria

-Active HBV infection

Trial design

15 participants in 1 patient group

HIV infected patients under injectable ART
Description:
HIV infected patients under injectable ART

Trial contacts and locations

1

Loading...

Central trial contact

Alissa NAQVI

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems